| Product Code: ETC7227816 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
France continues to rely on imports of quinolones, with top exporters in 2024 including Austria, Switzerland, India, China, and Germany. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a negative Compound Annual Growth Rate (CAGR) from 2020-2024, there was a significant growth rate spike from 2023-2024 at 164.31%. This suggests a dynamic market landscape with potential shifts in sourcing and demand for quinolones in France.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Quinolones Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 France Quinolones Market - Industry Life Cycle |
3.4 France Quinolones Market - Porter's Five Forces |
3.5 France Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 France Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 France Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 France Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 France Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 France Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in France |
4.2.2 Rising awareness about the effectiveness of quinolones in treating various infections |
4.2.3 Growing demand for antibiotics due to the aging population in France |
4.3 Market Restraints |
4.3.1 Growing concerns about antibiotic resistance and misuse |
4.3.2 Stringent regulations and restrictions on the use of quinolones in certain medical conditions |
5 France Quinolones Market Trends |
6 France Quinolones Market, By Types |
6.1 France Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 France Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 France Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 France Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 France Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 France Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 France Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 France Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 France Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 France Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 France Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 France Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 France Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 France Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 France Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 France Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 France Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 France Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 France Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 France Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 France Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 France Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 France Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 France Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 France Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 France Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 France Quinolones Market Import-Export Trade Statistics |
7.1 France Quinolones Market Export to Major Countries |
7.2 France Quinolones Market Imports from Major Countries |
8 France Quinolones Market Key Performance Indicators |
8.1 Prescription rate of quinolones by healthcare providers in France |
8.2 Patient adherence to quinolone treatment regimens |
8.3 Number of research studies and clinical trials on new applications of quinolones |
8.4 Rate of adverse reactions or side effects reported for quinolone usage |
8.5 Percentage of hospitals or healthcare facilities in France stocking and administering quinolones |
9 France Quinolones Market - Opportunity Assessment |
9.1 France Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 France Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 France Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 France Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 France Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 France Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Quinolones Market - Competitive Landscape |
10.1 France Quinolones Market Revenue Share, By Companies, 2024 |
10.2 France Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |